Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC için istatistikler
Toplam ziyaret
views | |
---|---|
Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ekim 2024 | 0 |
Kasım 2024 | 0 |
Aralık 2024 | 0 |
Ocak 2025 | 0 |
Şubat 2025 | 0 |
Mart 2025 | 0 |
Nisan 2025 | 0 |